tiprankstipranks
Innate Pharma (IPHA)
NASDAQ:IPHA
US Market
IPHA
Innate Pharma
RESEARCH TOOLSreports

Innate Pharma (IPHA) Stock News & Sentiment

132 Followers
Innate Pharma: Underappreciated Topo‑I ADC Pipeline and Differentiated IPH4502 Support Buy Rating
Premium
Ratings
Innate Pharma: Underappreciated Topo‑I ADC Pipeline and Differentiated IPH4502 Support Buy Rating
2d ago
IPHA
Innate Pharma: Diversified Oncology Pipeline and AstraZeneca Partnership Create Compelling Upside Ahead of 2026 Inflection Points
Premium
Ratings
Innate Pharma: Diversified Oncology Pipeline and AstraZeneca Partnership Create Compelling Upside Ahead of 2026 Inflection Points
29d ago
IPHA
Innate Pharma SA Reports First Half 2025 Financial Results
Premium
Company Announcements
Innate Pharma SA Reports First Half 2025 Financial Results
7M ago
IPHA
Innate Pharma’s Strategic Shift and Financial Challenges Lead to Hold Rating
Premium
Ratings
Innate Pharma’s Strategic Shift and Financial Challenges Lead to Hold Rating
7M ago
IPHA
Premium
Company Announcements
Innate Pharma’s IPH4502 Study: A New Hope in Cancer Treatment
9M ago
IPHA
Innate Pharma: Navigating Challenges with Promising Pipeline and Strategic Partnerships
Premium
Ratings
Innate Pharma: Navigating Challenges with Promising Pipeline and Strategic Partnerships
12M ago
IPHA
Innate Pharma: Promising Pipeline and Strategic Developments Drive Buy Rating
Premium
Ratings
Innate Pharma: Promising Pipeline and Strategic Developments Drive Buy Rating
1y ago
IPHA
More IPHA News >

IPHA News on the Web

Innate Pharma: Underappreciated Topo‑I ADC Pipeline and Differentiated IPH4502 Support Buy Rating
TipRanks News
Neutral
Innate Pharma SA (IPHA) Full Year 2025 Earnings Call Highlights: Strategic Advances and ...
GuruFocus News
Neutral
Full Year 2025 Innate Pharma SA Earnings Call Transcript
GuruFocus News
Neutral
Innate Pharma assumed with a Buy at BTIG
TipRanks News
Bullish
Innate Pharma: Diversified Oncology Pipeline and AstraZeneca Partnership Create Compelling Upside Ahead of 2026 Inflection Points
TipRanks News
Bullish
Why Innate Pharma S.A.’s (IPHA) Stock Is Up 5.30%
AAII
Neutral
Why Innate Pharma S.A.’s (IPHA) Stock Is Down 5.66%
AAII
Neutral
Why Innate Pharma S.A.’s (IPHA) Stock Is Up 5.52%
AAII
Neutral

News Score - Last 7 Days

Neutral
IPHA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IPHA’s Media Buzz Sentiment?
1 articles about IPHA were published this week. In an average week, 1 articles are published.
    What is IPHA’s weekly average amount of articles?
    In an average week, 1 articles about IPHA are published.
      What is IPHA’s News Sentiment?
      50% of articles about IPHA were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week